Skip to main content

COVID-19

RheumNow Podcast – Mistakes with Steroids

Apr 08, 2021

Dr Jack Cush gives his spin on this week's RheumNews and Rheum Research from RheumNow.com.

Read Article

Rheumatology Care Derailed by COVID-19

Apr 06, 2021

A survey study from the  ArthritisPower PPRN or CreakyJoints database shows that during the COVID-19 pandemic patient care was substantially affected in unforeseen ways.



Data from the ArthritisPower Patient-Powered Research Network and CreakyJoints patient community were gathered by

Read Article

Reactogenicity Following mRNA COVID-19 Vaccines

Apr 06, 2021

JAMA has published the real-world reporting of mRNA vaccine side effects (reactogenicity) gathered from CDC V-safe Surveillance system and shows that local and systemic reactions were often mild and transient and most commonly seen during the first day following their second dose.

Read Article
Survey of 500 pts with systemic rheumatic diseases during the COVID-19 pandemic showed few who discontinuations Rx - 2.2% D/C for fear of immunosuppression; 3.8% for shortages (mostly HCQ); 2.6%) for resp infx and 6% for side-effects. https://t.co/2BJIYeBSIu

Dr. John Cush @RheumNow( View Tweet )

Mar 23, 2021

RheumNow Podcast – Great Associations (3.19.2021)

Mar 18, 2021

Dr. Jack Cush rants on the journal reports, news and FDA actions featured this past week on RheumNow.com.

Read Article
Hydroxychloroquine studied vs Vitamin C (PBO) prophylaxis to households (n=671) exposed to COVID-19. 89% were COVD1-9 test neg at baseline. HCQ did not protect against progression to COVID (53 vs 45 events; adj HR, 1.10 [95% CI, 0.73 to 1.66]. A vit C Win! https://t.co/S5qjdIYaXq

Dr. John Cush @RheumNow( View Tweet )

Mar 18, 2021
News Feature: Comparison of Three Coronavirus Vaccines https://t.co/omxsA8W3nQ https://t.co/s7dc9NwMQo
Dr. John Cush @RheumNow( View Tweet )
Mar 17, 2021
News Feature: Rheumatic Patients Are at Risk for COVID Death https://t.co/bhJG1vuVA4 https://t.co/VEN3nwSOPB
Dr. John Cush @RheumNow( View Tweet )
Mar 17, 2021
REMDACTA trial of Actemra plus remdesivir failed to meet its primary endpoint of improved time to hospital discharge for patients with severe COVID-19 pneumonia (nor its key secondary endpoints) compared to remdesivir alone https://t.co/OyqpnwUVXU

Dr. John Cush @RheumNow( View Tweet )

Mar 17, 2021

Rheumatic Patients Are at Risk for COVID Death

MedPage Today
Mar 16, 2021

Patients with rheumatic diseases who developed COVID-19 were at increased likelihood of death, with risk factors similar to those seen in the general population but also because of factors specific to their underlying disease and its treatment, analysis of data from an international registry

Read Article
News Feature: Low Anaphylaxis Risk with COVID mRNA Vaccines JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals. https://t.co/hN7UWNasQo https://t.co/0UhOZuGze1
Dr. John Cush @RheumNow( View Tweet )
Mar 16, 2021
COVID Vaccine Rebuttals by Dr. Kathryn Dao ( @KDAO2011) Dr. Dao addresses the common vaccine concerns that have been posed to her and her rebuttals. https://t.co/f5gwBICEGy https://t.co/Nzm1HfY5GW
Dr. John Cush @RheumNow( View Tweet )
Mar 16, 2021
News Feature: Low Anaphylaxis Risk with COVID mRNA Vaccines JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals. https://t.co/hN7UWNasQo https://t.co/pVlaTUSCH7
Dr. John Cush @RheumNow( View Tweet )
Mar 13, 2021
News Feature: COVID-19-Related Deaths in Rheumatic Disease Patients There is a growing body of evidence regarding COVID-19 outcomes (including death) in rheumatic disease patients... https://t.co/N3SGTnTjsq https://t.co/Xlnt3oxKbo
Dr. John Cush @RheumNow( View Tweet )
Mar 12, 2021

RheumNow Podcast – Listener Questions (3.12.2021)

Mar 12, 2021

Dr Jack Cush reviews the news, Journal reports, CDC guidelines and viewer questions from the last week on RheumNow.com

Read Article

Low Anaphylaxis Risk with COVID mRNA Vaccines

Mar 12, 2021

JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals. 



Prior studies suggested the risk of anaphylaxis to the mRNA COVID-19 vaccines may be as low as 2.5 - 11.1 cases per million doses and that such

Read Article

COVID-19-Related Deaths in Rheumatic Disease Patients

Mar 11, 2021

There is a growing body of evidence regarding COVID-19 outcomes (including death) in rheumatic disease patients; analysis of a German registry shows that poor control, rituximab, sulfasalazine and other immunosuppressives could be risk factors for COVID-related death.



The early data

Read Article

Comparison of Three Coronavirus Vaccines

Mar 10, 2021

On Feb. 27, the Food and Drug Administration announced it has issued an emergency use authorization for Johnson & Johnson’s one-dose Covid vaccine, making it the third COVID-19 vaccine to be commercially available.  We've compiled a comparison table and some key information relevant to your

Read Article
News Feature: CDC: Interim Guidance for COVID Vaccinated People https://t.co/3GZDCVF0hv https://t.co/qyQyajjqM8
Dr. John Cush @RheumNow( View Tweet )
Mar 10, 2021

CDC: Interim Guidance for COVID Vaccinated People

Mar 09, 2021

Among 330 million Americans, roughly 32.1 million have been fully vaccinated and 61.1 million have received at least one dose of a COVID-19 vaccine (as of March 8th).



The CDC has issued new guidelines for those who have taken the COVID Vaccine, acknowledging the potential benefits of

Read Article
Data Safety committee has closed recruitment to the colchicine arm in the RECOVERY trial a UK study of outcomes in COVID-19. Among 11162 enrolled pts (2178 deaths) those Rx w/ Colchicine had same 28 day mortality as usual care (20% vs. 19%) https://t.co/8gUc8LAZTp

Dr. John Cush @RheumNow( View Tweet )

Mar 09, 2021
News Feature: Baricitinib Therapy in Covid-19 Pneumonia https://t.co/b3tsLcoXay https://t.co/tjqkk1RLFZ
Dr. John Cush @RheumNow( View Tweet )
Mar 06, 2021
Influenza Numbers are way down this year due to COVID mitigation methods, school/office closings, reduced travel/mobility. As of Jan 31st only 155 hospitalized with the flu (98% less than 2019-2020 flu season - 8,633 people were hospitalized with the flu) https://t.co/6c2YQKbt57?

Dr. John Cush @RheumNow( View Tweet )

Mar 05, 2021

RheumNow Podcast – Pounds of Prevention (3.5.2021)

Mar 04, 2021

Dr. Jack Cush reviews and discusses nearly a dozen news reports and journal articles from the past week on RheumNow.com.

Read Article

Baricitinib Therapy in Covid-19 Pneumonia

Mar 04, 2021

The NEJM has published the results of the ACCT-2 Study,  a double-blind, randomized, placebo-controlled trial evaluating baricitinib, an inhibitor of Janus kinase 1 (JAK1) and JAK2, plus remdesivir in hospitalized adults with Covid-19. The primary outcome was the time to recovery. The key

Read Article
×